Comparison of topical nepafenac 0.1% and 0.3% on aqueous flare and macular thickness in patients with pseudoexfoliation following cataract surgery
Nepafenac 0.3% used in routine cataract surgery in patients with PEX was shown to be at least as effective as nepafenac 0.1% in terms of aqueous flare and CMT. Aqueous flare values were more favorable with nepafenac 0.3% during the first week. In addition, the convenience of once-daily dosing may offer further advantages.
Authors
- Fahri Onur Aydın (ORCID: https://orcid.org/0000-0001-9414-6788)
- Zeynep Şerikoğlu Akbaş (ORCID: https://orcid.org/0000-0002-7711-743X)
- Yusuf Yıldırım (ORCID: https://orcid.org/0000-0002-4161-0919)
- Yusuf Berk Akbaş (ORCID: https://orcid.org/0000-0001-8613-5560)
- Semih Çakmak (ORCID: https://orcid.org/0000-0003-2638-0569)
- Burçin Kepez Yıldız (ORCID: https://orcid.org/0000-0001-5977-2601)
- Ali Ceylan (ORCID: https://orcid.org/0000-0002-3446-7640)
- Merve Kelebek
Institutions
- Istanbul Metropolitan Municipality (TR)
- Istanbul University-Cerrahpaşa (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Indian Journal of Ophthalmology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.4103/ijo.ijo_2916_24
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00